News

With the stock market nearly all the way back to where it started the year, some may think the rally of the last few months may be running out of steam. While I'm not sure that's the case -- it's

Gilead Sciences (NASDAQ: GILD) is among many biotech and pharmaceutical companies working on treatments for COVID-19, the illness caused by the novel coronavirus. Where Gilead stands apart is it

More than 20 million Americans are out of work and receiving unemployment benefits, largely due to the COVID-19 pandemic. And yet, you wouldn't know that there's a problem in the economy from

Social Security is in trouble. In April, the program's Trustees reported that Social Security's trust funds could run out of money by 2035. Once that happens, the program may have no choice but to

Health savings accounts (HSAs) are one of the most valuable tax-advantaged investments, but they're often overlooked.

HSAs aren't open to everyone; you need a qualifying high-deductible health plan

For the last three years, Gilead Sciences (NASDAQ: GILD) hasn't done much more than treading water. Sure, the stock is up during the period, but all of the gains came in 2020 with COVID-19 drug

If the coronavirus disease 2019 (COVID-19) pandemic has taught investors anything, it's that staying the course on great companies, no matter how dire things may seem, is almost always a prudent

Millions of Americans have lost their jobs in the wake of COVID-19, and earlier this month, economists declared that we have a full-blown recession on our hands. Thankfully, there's been relief for

Teladoc Health (NYSE: TDOC) is the leader of telemedicine in the U.S. With its massive network of board-certified clinicians, Teladoc aims to supply health insurance companies and large employers

Your 401(k) was supposed to be your ticket to a nice retirement. And it sure seemed like you were heading in the right direction, right up until 2020 happened. Now, your account balance is down and

Three hundred to one. Those were the odds against the U.S. legalizing marijuana at the federal level that I calculated 10 months ago. I didn't just pull those numbers out of thin air. They were

Aurora Cannabis (NYSE: ACB) remains one of the most talked-about cannabis companies on the market. Its rise and fall (and the beginning of another rise) have without question intrigued investors

There's no amount of money that is too small to build out your stock portfolio these days. With more and more brokers offering fractional and slices of shares, you can stake your claim in some of

As the COVID-19 pandemic worsened in the United States earlier this year, the Treasury Department moved the deadline for individual income tax returns to July 15, three months later than the usual

HEXO (NYSE: HEXO) released its earnings report for the third quarter of fiscal year 2020 on June 11, and the pot grower managed to impress investors for a change. During this quarter, HEXO's net

We can sometimes overcomplicate investing. But it can -- and should -- be pretty simple. Find a well-run company with great growth prospects. Buy the stock. And sit back while it appreciates over

Although around 35 million people are still waiting for their first coronavirus stimulus check, the majority of Americans have now received COVID-19 payments authorized by the Coronavirus Aid,

Moderna (NASDAQ: MRNA) is living the dream that most biotechs aspire to achieve. In late 2018, the company pulled off what was at the time the biggest initial public offering (IPO) in biotech

The COVID-19 crisis has had a huge economic impact ever since U.S. case numbers started climbing in March. Not only have millions of Americans lost their jobs in its wake, but investment and

Do you think the stock market could crash again? Join the club. A Bank of America survey of 200 fund managers in May found that over two-thirds of them see the current rebound as only a "bear market

There's little question that we're going to be talking about 2020 for a long time to come. The unprecedented coronavirus disease 2019 (COVID-19) pandemic has completely upended societal norms and

Stocks posted modest gains last week as major parts of the U.S. economy reopened following COVID-19 shutdowns. Both the Dow Jones Industrial Average (DJINDICES: ^DJI) and the S&P 500 (SNPINDEX:

Bristol Myers Squibb (NYSE: BMY) has long been an investor favorite for a few reasons. In December, the company increased its dividend for 2020 by 9.8%, which now yields 3.2%. Bristol Myers has a

For much of 2020, the American worker has been tested like never before. Panic and uncertainty tied to the coronavirus disease 2019 (COVID-19) led most governors to shut down essential businesses in

Warnings abound about impending Social Security benefit cuts if the program's finances aren't fixed in the coming years. While an automatic benefit cut could become necessary in 2035 when the